Spyre Therapeutics, Inc. (SYRE)

NASDAQ: SYRE · Real-Time Price · USD

30.58

-2.18 (-6.65%)

At close: Jan 2, 2026, 4:00 PM EST

31.19

+0.61 (1.99%)

After-hours: Jan 2, 2026, 7:18 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2013 - 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2013 - 2016
Biopharmaceutical Products	886.00K	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceutical Products Growth	-61.96%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2018	FY 2017	2013 - 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2013 - 2016
United States	886.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-61.96%	Log In	Log In	Log In	Log In	Upgrade